BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19321799)

  • 1. Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts.
    Zibat A; Uhmann A; Nitzki F; Wijgerde M; Frommhold A; Heller T; Armstrong V; Wojnowski L; Quintanilla-Martinez L; Reifenberger J; Schulz-Schaeffer W; Hahn H
    Carcinogenesis; 2009 Jun; 30(6):918-26. PubMed ID: 19321799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unbalanced overexpression of the mutant allele in murine Patched mutants.
    Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H
    Carcinogenesis; 2002 May; 23(5):727-33. PubMed ID: 12016144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice.
    Ecke I; Petry F; Rosenberger A; Tauber S; Mönkemeyer S; Hess I; Dullin C; Kimmina S; Pirngruber J; Johnsen SA; Uhmann A; Nitzki F; Wojnowski L; Schulz-Schaeffer W; Witt O; Hahn H
    Cancer Res; 2009 Feb; 69(3):887-95. PubMed ID: 19155313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMBA/TPA treatment is necessary for BCC formation from patched deficient epidermal cells in Ptch(flox/flox)CD4Cre(+/-) mice.
    Uhmann A; Heß I; Frommhold A; König S; Zabel S; Nitzki F; Dittmann K; Lühder F; Christiansen H; Reifenberger J; Schulz-Schaeffer W; Hahn H
    J Invest Dermatol; 2014 Oct; 134(10):2620-2629. PubMed ID: 24662765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development.
    Tostar U; Malm CJ; Meis-Kindblom JM; Kindblom LG; Toftgård R; Undén AB
    J Pathol; 2006 Jan; 208(1):17-25. PubMed ID: 16294371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
    Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H
    Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study.
    Soufir N; Gerard B; Portela M; Brice A; Liboutet M; Saiag P; Descamps V; Kerob D; Wolkenstein P; Gorin I; Lebbe C; Dupin N; Crickx B; Basset-Seguin N; Grandchamp B
    Br J Cancer; 2006 Aug; 95(4):548-53. PubMed ID: 16909134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV fingerprints predominate in the PTCH mutation spectra of basal cell carcinomas independent of clinical phenotype.
    Heitzer E; Lassacher A; Quehenberger F; Kerl H; Wolf P
    J Invest Dermatol; 2007 Dec; 127(12):2872-81. PubMed ID: 17597822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
    Reifenberger J; Wolter M; Knobbe CB; Köhler B; Schönicke A; Scharwächter C; Kumar K; Blaschke B; Ruzicka T; Reifenberger G
    Br J Dermatol; 2005 Jan; 152(1):43-51. PubMed ID: 15656799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the PTCH coding region in human rhabdomyosarcoma.
    Calzada-Wack J; Schnitzbauer U; Walch A; Wurster KH; Kappler R; Nathrath M; Hahn H
    Hum Mutat; 2002 Sep; 20(3):233-4. PubMed ID: 12204003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
    Reifenberger J; Wolter M; Weber RG; Megahed M; Ruzicka T; Lichter P; Reifenberger G
    Cancer Res; 1998 May; 58(9):1798-803. PubMed ID: 9581815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of cutaneous macrophages and dendritic cells promotes growth of basal cell carcinoma in mice.
    König S; Nitzki F; Uhmann A; Dittmann K; Theiss-Suennemann J; Herrmann M; Reichardt HM; Schwendener R; Pukrop T; Schulz-Schaeffer W; Hahn H
    PLoS One; 2014; 9(4):e93555. PubMed ID: 24691432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of patched mutations in a collection of Australian basal cell carcinomas.
    Evans T; Boonchai W; Shanley S; Smyth I; Gillies S; Georgas K; Wainwright B; Chenevix-Trench G; Wicking C
    Hum Mutat; 2000; 16(1):43-8. PubMed ID: 10874304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation.
    Unden AB; Holmberg E; Lundh-Rozell B; Stähle-Bäckdahl M; Zaphiropoulos PG; Toftgård R; Vorechovsky I
    Cancer Res; 1996 Oct; 56(20):4562-5. PubMed ID: 8840960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset of sporadic basal-cell carcinoma: germline mutations in the TP53, PTCH, and XPD genes.
    Suárez-Martínez EB; Ruiz A; Matías J; Morales L; Cruz A; Vázquez D; Villa J; Matta JL
    P R Health Sci J; 2007 Dec; 26(4):349-54. PubMed ID: 18246963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTCH mutations are not mainly involved in the pathogenesis of sporadic trichoblastomas.
    Hafner C; Schmiemann V; Ruetten A; Coras B; Landthaler M; Reifenberger J; Vogt T
    Hum Pathol; 2007 Oct; 38(10):1496-500. PubMed ID: 17597182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.
    Nitzki F; Zibat A; Frommhold A; Schneider A; Schulz-Schaeffer W; Braun T; Hahn H
    Oncogene; 2011 Oct; 30(43):4428-36. PubMed ID: 21602886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin.
    Danaee H; Karagas MR; Kelsey KT; Perry AE; Nelson HH
    J Invest Dermatol; 2006 May; 126(5):1152-8. PubMed ID: 16484983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of p16 and PTCH in pathogenesis of melanoma and basal cell carcinoma.
    Cretnik M; Poje G; Musani V; Kruslin B; Ozretic P; Tomas D; Situm M; Levanat S
    Int J Oncol; 2009 Apr; 34(4):1045-50. PubMed ID: 19287961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UV-specific p53 and PTCH mutations in sporadic basal cell carcinoma of sun-exposed skin.
    Ratner D; Peacocke M; Zhang H; Ping XL; Tsou HC
    J Am Acad Dermatol; 2001 Feb; 44(2):293-7. PubMed ID: 11174390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.